<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/31402" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/31402</id>
  <updated>2026-04-11T18:25:00Z</updated>
  <dc:date>2026-04-11T18:25:00Z</dc:date>
  <entry>
    <title>Comparative assessment of active compounds in Solidago species from the flora of the Republic of Moldova</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/31431" />
    <author>
      <name>Fursenco, Cornelia</name>
    </author>
    <author>
      <name>Ion, Violeta Alexandra</name>
    </author>
    <author>
      <name>Calalb, Tatiana</name>
    </author>
    <author>
      <name>Uncu, Livia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/31431</id>
    <updated>2025-11-06T08:19:45Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Comparative assessment of active compounds in Solidago species from the flora of the Republic of Moldova
Authors: Fursenco, Cornelia; Ion, Violeta Alexandra; Calalb, Tatiana; Uncu, Livia
Abstract: Introduction. Solidago virgaurea (European goldenrod) and Solidago canadensis (Canadian goldenrod) are two plant species&#xD;
that have been extensively investigated for their complex phytochemical profiles, particularly represented by flavonoids,&#xD;
phenolic acids, saponins, and essential oils with notable antioxidant and anti-inflammatory properties.&#xD;
Material and methods. Goldenrod plants were collected during the flowering period (2019–2024), S. virgaurea obtained&#xD;
from spontaneous flora and S. canadensis from the Scientific-Practical Center in the Domain of Medicinal Plants of Nicolae&#xD;
Testemitanu State University of Medicine and Pharmacy. The macroscopic analysis was performed using specific morphological&#xD;
indices of the Herba vegetal product, while the microscopic examination was performed on superficial preparations&#xD;
and cross-sections of vegetal material using a Micros microscope equipped with a digital imaging system. Dry extracts were&#xD;
prepared using repeated maceration, followed by phytochemical investigations employing qualitative color and sedimentation&#xD;
tests, ultraviolet-visible spectrophotometry (for total polyphenolic compounds, flavonoids, hydroxycinnamic acids,&#xD;
carotenoids, and saponins), and gas chromatography-mass spectrometry for essential oils. The antioxidant potential was&#xD;
assessed in vitro using the 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) radical scavenging assay and the metal&#xD;
chelation method. In vivo pharmacological studies included antimicrobial activity, assessed via serial dilution in liquid&#xD;
nutrient media, and anti-inflammatory activity, evaluated using the xylene-induced ear edema model in mice and the carrageenan-&#xD;
induced paw edema model in rats.&#xD;
Results. The biological, macroscopic, and microscopic investigations established reliable diagnostic criteria for the clear&#xD;
differentiation and identification of Herba-type vegetal products derived from the two Solidago species from the Moldovan&#xD;
flora. Qualitative phytochemical screening using specific color and sedimentation reactions confirmed the presence of&#xD;
flavonoids and triterpenic saponins in the examined vegetal products. Quantitative ultraviolet-visible spectrophotometric&#xD;
analysis revealed that S. canadensis contained relatively higher levels of bioactive compounds–flavonoids, hydroxycinnamic&#xD;
acids, saponins, and carotenoids–and exhibited greater antioxidant activity compared to S. virgaurea. Gas chromatography-&#xD;
mass spectrometry analysis showed that the essential oils of both species differ more quantitatively than qualitatively.&#xD;
Both Solidago species exhibited moderate anti-inflammatory and antibacterial activities.&#xD;
Conclusions. The results of this complex study support the selection of the vegetal product Solidaginis canadensis herba&#xD;
as a promising candidate for the local pharmaceutical industry, serving as a valuable source of new local plant-derived&#xD;
antioxidant, anti-inflammatory, and antibacterial drugs.</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Tuberculosis in new cases: the impact of HIV status on clinical manifestations</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/31430" />
    <author>
      <name>Ivanes, Igor</name>
    </author>
    <author>
      <name>Ustian, Aurelia</name>
    </author>
    <author>
      <name>Iavorschi, Constantin</name>
    </author>
    <author>
      <name>Corlăteanu, Alexandru</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/31430</id>
    <updated>2025-11-06T08:09:57Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Tuberculosis in new cases: the impact of HIV status on clinical manifestations
Authors: Ivanes, Igor; Ustian, Aurelia; Iavorschi, Constantin; Corlăteanu, Alexandru
Abstract: Introduction. Tuberculosis continues to be the primary cause of death among individuals living with human immunodeficiency&#xD;
virus, with co-infection significantly influencing the clinical course, severity, and outcomes of the disease. Although&#xD;
the interaction between the two conditions is well recognized, regional data from Eastern Europe remain insufficient.&#xD;
Material and methods. A retrospective, cross-sectional comparative study was carried out in the Republic of Moldova in&#xD;
2021. A total of 320 patients with newly diagnosed pulmonary tuberculosis were included and divided into two matched&#xD;
groups: the study group consisted of 160 patients with confirmed human immunodeficiency virus co-infection, and the&#xD;
control group included 160 patients without human immunodeficiency virus infection. The groups were comparable in&#xD;
terms of age, sex, residence, and resistance profile of Mycobacterium tuberculosis. Data were collected from national clinical&#xD;
records and analyzed using descriptive statistical methods.&#xD;
Results. Among 320 patients, those with HIV co-infection had significantly higher rates of generalized TB (28.8% vs. 2.5%;&#xD;
p &lt; 0.0001), subacute onset (71.9% vs. 22.5%; p &lt; 0.0001), and severe/very severe condition at diagnosis (27.4% vs.&#xD;
10.6%; p = 0.0017). Anemia (58.8% vs. 23.1%; OR = 4.73, p &lt; 0.0001), leukopenia (16.3% vs. 1.3%; OR = 15.33, p &lt; 0.0001),&#xD;
and ESR &gt;60 mm/h (25.0% vs. 5.6%; OR = 5.59, p &lt; 0.0001) were significantly more common in co-infected patients. Bilateral&#xD;
lung lesions were more frequent (65.6% vs. 59.4%), while cavitary destruction predominated in TB-only patients&#xD;
(59.4% vs. 34.4%; p &lt; 0.0001). Smear positivity was lower in the HIV group (38.8% vs. 55.0%; p = 0.0036). Complications&#xD;
(48.1% vs. 20.6%; p &lt; 0.0001) and opportunistic infections (17.5% vs. 0%) were more prevalent in co-infected patients.&#xD;
Mortality was significantly higher among HIV-positive cases (28.1% vs. 6.9%; OR = 5.20, p &lt; 0.0001).&#xD;
Conclusions. Human immunodeficiency virus infection significantly modifies the clinical presentation of tuberculosis,&#xD;
favoring more severe, atypical, and extrapulmonary forms, along with higher complication rates and mortality. These findings&#xD;
highlight the urgent need for early diagnosis, adapted diagnostic approaches, and integrated treatment strategies in&#xD;
patients with dual infection, particularly in high-burden settings.</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Identifying core stigmatizing beliefs about depression: results from an item-level statistical approach</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/31429" />
    <author>
      <name>Chihai, Jana</name>
    </author>
    <author>
      <name>Esanu, Andrei</name>
    </author>
    <author>
      <name>Nastas, Igor</name>
    </author>
    <author>
      <name>Deliv, Inga</name>
    </author>
    <author>
      <name>Bologan, Alina</name>
    </author>
    <author>
      <name>Adeola, Cornelia</name>
    </author>
    <author>
      <name>Coșulean, Radislav</name>
    </author>
    <author>
      <name>Bivol, Madalina</name>
    </author>
    <author>
      <name>Belous, Mihaela</name>
    </author>
    <author>
      <name>Jelaga, Dorin</name>
    </author>
    <author>
      <name>Popescu, Romil</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/31429</id>
    <updated>2025-11-06T08:02:56Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: Identifying core stigmatizing beliefs about depression: results from an item-level statistical approach
Authors: Chihai, Jana; Esanu, Andrei; Nastas, Igor; Deliv, Inga; Bologan, Alina; Adeola, Cornelia; Coșulean, Radislav; Bivol, Madalina; Belous, Mihaela; Jelaga, Dorin; Popescu, Romil
Abstract: Introduction. Stigma surrounding depression continues to be a major barrier to treatment, social inclusion, and recovery.&#xD;
While general attitudes toward mental illness have been widely studied, fewer investigations have focused on the specific&#xD;
beliefs that drive stigma toward individuals with depression in a low- and middle-income country (LMIC) in Eastern European&#xD;
settings, particularly in Moldova.&#xD;
Material and methods. A cross-sectional study was conducted with a sample of 460 participants from Moldova, who&#xD;
completed the Depression Stigma Scale. Each of the nine items reflected a different stigmatizing belief about depression.&#xD;
Descriptive statistics, including mean scores and standard deviations, were calculated for each item. An item-level comparative&#xD;
analysis was performed.&#xD;
Results. The highest stigma scores were recorded for items such as: “I would not employ someone if I knew they had been&#xD;
depressed”, “Depression is not a real medical illness”, and “Depression is a sign of personal weakness.” The lowest scores&#xD;
were observed for beliefs related to dangerousness and avoidance, including “People with depression are dangerous” and&#xD;
“It is best to avoid people with depression so you don’t become depressed yourself.” These results suggest that stigma in&#xD;
Moldova is predominantly characterized by doubts about the medical legitimacy of depression and concerns over professional&#xD;
roles, rather than fear-based or exclusionary attitudes.&#xD;
Conclusions. Anti-stigma interventions in LMICs, such as Moldova should prioritize improving public understanding of&#xD;
depression as a legitimate health condition and addressing discrimination in professional settings.</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>The effectiveness of using a checklist in prehospital stroke interventions in the Republic of Moldova</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/31428" />
    <author>
      <name>Catanoi, Natalia</name>
    </author>
    <author>
      <name>Peștereanu, Mihail</name>
    </author>
    <author>
      <name>Rezneac, Larisa</name>
    </author>
    <author>
      <name>Mocanu, Natalia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/31428</id>
    <updated>2025-11-05T16:57:00Z</updated>
    <published>2025-01-01T00:00:00Z</published>
    <summary type="text">Title: The effectiveness of using a checklist in prehospital stroke interventions in the Republic of Moldova
Authors: Catanoi, Natalia; Peștereanu, Mihail; Rezneac, Larisa; Mocanu, Natalia
Abstract: Introduction. Stroke remains a major cause of mortality and disability in Moldova and globally. Rapid prehospital intervention&#xD;
is critical for improving outcomes. The adoption of standardized protocols and checklists has enhanced the efficiency&#xD;
of emergency medical services (EMS), especially in stroke recognition and initial management.&#xD;
Materials and methods. A systematic review of the literature and analysis of statistical data from the National Prehospital&#xD;
Emergency Medical Service were conducted. The study focused on evaluating the use and impact of checklists during&#xD;
prehospital stroke interventions.&#xD;
Results. Between 2022 and 2023, over 12,000 stroke cases were recorded annually. The implementation of national checklists,&#xD;
in conjunction with the Face, Arm, Speech, Time scale, significantly improved early identification, triage, and transport to&#xD;
specialized centers. Notable outcomes included a higher rate of thrombolysis and thrombectomy, improved coordination, and&#xD;
a modest reduction in overall response time. However, delays due to inter-hospital transfers remain a challenge.&#xD;
Conclusions. The systematic use of checklists in prehospital stroke management in Moldova proved effective in standardizing&#xD;
care, accelerating intervention, and improving patient outcomes. Continued training and system reorganization are&#xD;
crucial to fully capitalize on these tools and to reduce stroke-related morbidity and mortality.</summary>
    <dc:date>2025-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

